College of Medicine and UA Arthritis Center, University of Arizona (UA), Tucson, AZ, USA.
Center for Health Equity Research and Promotion (CHERP), VA Pittsburgh Healthcare System (VAPHS), Pittsburgh, PA, USA; School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Osteoarthritis Cartilage. 2019 Jul;27(7):1018-1025. doi: 10.1016/j.joca.2019.01.010. Epub 2019 Feb 1.
Determine modifiable social and psychological health factors that are associated with use of oral opioid and non-opioid medications for OA.
Patients were categorized based on use of the following oral medications: opioids (with/without other oral analgesic treatments), non-opioid analgesics, and no oral analgesic treatment. We used multinomial logistic regression models to estimate adjusted relative risk ratios (RRRs) of using an opioid or a non-opioid analgesic (vs. no oral analgesic treatment), comparing patients by levels of social support (Medical Outcomes Study scale), health literacy ("How confident are you filling out medical forms by yourself?"), and depressive symptoms (Patient Health Questionnaire-8). Models were adjusted for demographic and clinical characteristics.
In this sample (mean age 64.2 years, 23.6% women), 30.6% (n = 110) reported taking opioid analgesics for OA, 54.2% (n = 195) reported non-opioid use, and 15.3% (n = 55) reported no oral analgesic use. Opioid users had lower mean social support scores (10.0 vs 10.5 vs 11.9, P = 0.007) and were more likely to have moderate-severe depressive symptoms (42.7% vs 24.1% vs 14.5%, P < 0.001). Health literacy did not differ by treatment group type. Having moderate-severe depression was associated with higher risk of opioid analgesic use compared to no oral analgesic use (RRR 2.96, 95%CI 1.08-8.07) when adjusted for sociodemographic and clinical factors. Neither social support nor health literacy was associated with opioid or non-opioid oral analgesic use in fully adjusted models.
Knee OA patients with more severe depression symptoms, compared to those without, were more likely to report using opioid analgesics for OA.
确定与 OA 使用口服阿片类药物和非阿片类药物相关的可改变的社会和心理健康因素。
根据以下口服药物的使用情况对患者进行分类:阿片类药物(有/无其他口服镇痛治疗)、非阿片类镇痛药和无口服镇痛治疗。我们使用多项逻辑回归模型来估计使用阿片类或非阿片类镇痛药(与无口服镇痛治疗相比)的调整后相对风险比(RRR),通过社会支持(医疗结局研究量表)、健康素养(“您自己填写医疗表格有多大信心?”)和抑郁症状(患者健康问卷-8)水平比较患者。模型调整了人口统计学和临床特征。
在这个样本中(平均年龄 64.2 岁,23.6%为女性),30.6%(n=110)报告使用阿片类镇痛药治疗 OA,54.2%(n=195)报告使用非阿片类药物,15.3%(n=55)报告无口服镇痛药使用。阿片类药物使用者的平均社会支持评分较低(10.0 与 10.5 与 11.9,P=0.007),且更有可能出现中重度抑郁症状(42.7%与 24.1%与 14.5%,P<0.001)。健康素养不因治疗组类型而异。在调整社会人口统计学和临床因素后,与无口服镇痛药使用相比,中重度抑郁与阿片类镇痛药治疗 OA 的风险更高(RRR 2.96,95%CI 1.08-8.07)。在完全调整的模型中,社会支持和健康素养均与阿片类或非阿片类口服镇痛药的使用无关。
与无抑郁症状的患者相比,膝关节 OA 患者中抑郁症状较严重者更有可能报告使用阿片类镇痛药治疗 OA。